Biomarkers for post-traumatic stress states
The present invention relates generally to the detection or diagnosis of post-traumatic stress states in a subject, and provides methods, reagents, and kits useful for this purpose. Provided herein are biomarkers that are indicative of and/or diagnostic of post-traumatic stress states including PTSD.
1. A panel of biomarkers consisting of an isolated set of 100 or fewer full-length cDNA biomarkers, wherein said isolated set includes SERPINB1, LILRB3, and GLRX full-length cDNA biomarkers.
2. The panel of biomarkers of claim 1 , comprising a full-length IFI27 cDNA biomarker.
3. The panel of biomarkers of claim 1 , comprising a full-length FUOM cDNA biomarker.
4. The panel of biomarkers of claim 1 , comprising a full-length HSPA8 cDNA biomarker.
5. The panel of biomarkers of claim 1 , comprising a full-length IGK cDNA biomarker.
6. The panel of biomarkers of claim 1 , comprising a full-length LCMT1 cDNA biomarker.
7. The panel of biomarkers of claim 1 , comprising a full-length THYN1 cDNA biomarker.
8. The panel of biomarkers of claim 1 , comprising a full-length SEC14L2 cDNA biomarker.
9. The panel of biomarkers of claim 1 , comprising a full-length SLC16A3 cDNA biomarker.
10. The panel of biomarkers of claim 1 , comprising a full-length SERINC2 cDNA biomarker.
11. The panel of biomarkers of claim 1 , comprising a full-length TRPM6 cDNA biomarker.
12. The panel of biomarkers of claim 1 , comprising a full-length XKRX cDNA biomarker.
13. The panel of biomarkers of claim 1 , comprising a full-length ADN cDNA biomarker.
14. The panel of biomarkers of claim 1 , comprising a full-length DGAT2 cDNA biomarker.
15. The panel of biomarkers of claim 1 , comprising a full-length PROK2 cDNA biomarker.
16. The panel of biomarkers of claim 1 , comprising a full-length TNFRSF1A cDNA biomarker.